Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07126535) titled 'Impact of RFA on Esophageal Distensibility and Mucosal Impedance' on Aug. 11.
Study Type: Observational
Primary Sponsor: Mayo Clinic
Condition:
Dysplastic Barrett's Esophagus
Radiofrequency Ablation
Barrett Esophagus
Intervention:
Diagnostic Test: Radiofrequency ablation alone
Recruitment Status: Not recruiting
Date of First Enrollment: September 25, 2025
Target Sample Size: 10
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07126535
Published by HT Digital Content Services with permission from Health Daily Digest....